The metabolomic quest for a biomarker in chronic kidney disease
- PMID: 30288265
- PMCID: PMC6165760
- DOI: 10.1093/ckj/sfy037
The metabolomic quest for a biomarker in chronic kidney disease
Abstract
Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which the diagnostics are niether disease-specific nor indicative of progression. Biomarkers are sought to enable clinicians to offer more appropriate patient-centred treatments, which could come to fruition by using a metabolomics approach. This mini-review highlights the current literature of metabolomics and CKD, and suggests additional factors that need to be considered in this quest for a biomarker, namely the diet and the gut microbiome, for more meaningful advances to be made.
Keywords: biomarkers; chronic kidney disease; diet; metabolomics.
Similar articles
-
Identification of Potential Biomarkers of Chronic Kidney Disease in Individuals with Diabetes: Protocol for a Cross-sectional Observational Study.JMIR Res Protoc. 2020 Jul 31;9(7):e16277. doi: 10.2196/16277. JMIR Res Protoc. 2020. PMID: 32734931 Free PMC article.
-
Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome.Biomedicines. 2020 Sep 10;8(9):341. doi: 10.3390/biomedicines8090341. Biomedicines. 2020. PMID: 32927866 Free PMC article. Review.
-
Metabolomics in chronic kidney disease.Clin Chim Acta. 2013 Jun 25;422:59-69. doi: 10.1016/j.cca.2013.03.033. Epub 2013 Apr 6. Clin Chim Acta. 2013. PMID: 23570820 Review.
-
Chronic kidney disease: Biomarker diagnosis to therapeutic targets.Clin Chim Acta. 2019 Dec;499:54-63. doi: 10.1016/j.cca.2019.08.030. Epub 2019 Aug 30. Clin Chim Acta. 2019. PMID: 31476302 Review.
-
Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.PLoS One. 2014 May 9;9(5):e96955. doi: 10.1371/journal.pone.0096955. eCollection 2014. PLoS One. 2014. PMID: 24817014 Free PMC article.
Cited by
-
Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine.J Pers Med. 2024 Dec 19;14(12):1157. doi: 10.3390/jpm14121157. J Pers Med. 2024. PMID: 39728069 Free PMC article. Review.
-
Varying Protein Levels Influence Metabolomics and the Gut Microbiome in Healthy Adult Dogs.Toxins (Basel). 2020 Aug 12;12(8):517. doi: 10.3390/toxins12080517. Toxins (Basel). 2020. PMID: 32806674 Free PMC article.
-
Chronic Kidney Disease Cohort Studies: A Guide to Metabolome Analyses.Metabolites. 2021 Jul 16;11(7):460. doi: 10.3390/metabo11070460. Metabolites. 2021. PMID: 34357354 Free PMC article. Review.
-
Exposome and Metabolome Analysis of Sugarcane Workers Reveals Predictors of Kidney Injury.Kidney Int Rep. 2024 Feb 6;9(5):1458-1472. doi: 10.1016/j.ekir.2024.01.060. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707825 Free PMC article.
-
Nuclear Magnetic Resonance-Based Metabolomics Approach Revealed the Intervention Effect of Using Complementary and Alternative Medicine (CAM) by CKD Patients.ACS Omega. 2023 Feb 16;8(8):7722-7737. doi: 10.1021/acsomega.2c06469. eCollection 2023 Feb 28. ACS Omega. 2023. PMID: 36872986 Free PMC article.
References
-
- Carrero J-J, Hecking M, Ulasi I. et al. Chronic kidney disease, gender, and access to care: a global perspective. Semin Nephrol 2017; 37: 296–308 - PubMed
-
- Kellum JA, Lameire N, Aspelin P. et al. Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2013; 2: 1–138
-
- NICE. Chronic Kidney Disease in Adults: Assessment and Management | Clinical Guideline [CG182] 2015. https://www.nice.org.uk/guidance/cg182 (28 November 2017, date last accessed)
LinkOut - more resources
Full Text Sources